AS ONE Corporation
Notice of January 2026 Standalone Monthly Performance (Preliminary)
Standalone sales for January 2026 increased 6.8% year-over-year. The Laboratory segment grew by 10.6%, Industry by 4.9%, and Medical declined by 4.1%.
Key Figures
- January 2026 Sales Year-over-Year: +6.8%
- Laboratory Segment Sales Year-over-Year: +10.6%
- Medical Segment Sales Year-over-Year: △4.1%
AI要約
Monthly Sales Trends and Segment Performance
Standalone sales for January 2026 increased 6.8% year-over-year, with the Laboratory segment growing 10.6% and the Industry segment up 4.9%, showing solid performance. Growth in e-commerce channels overall and high-value transactions (up 18% YoY) drove sales. Meanwhile, the Medical segment declined 4.1%, despite active consumables sales, due to weak demand for equipment. The number of business days remained unchanged compared to the same month last year, with sales per day showing an increasing trend year-over-year.
Nature of This Report and Future Disclosures
This report provides partial preliminary figures for the three main standalone business segments and does not reflect adjustments for internal transactions or deductions. For reference, the standalone fiscal 2024 sales amounted to JPY 99,397 million, and consolidated sales reached JPY 103,751 million. Results for June, September, December, and March will be disclosed at the time of the financial summary announcements.
